US5843156A
(en)
|
1988-08-24 |
1998-12-01 |
Endoluminal Therapeutics, Inc. |
Local polymeric gel cellular therapy
|
US5575815A
(en)
*
|
1988-08-24 |
1996-11-19 |
Endoluminal Therapeutics, Inc. |
Local polymeric gel therapy
|
US5328471A
(en)
*
|
1990-02-26 |
1994-07-12 |
Endoluminal Therapeutics, Inc. |
Method and apparatus for treatment of focal disease in hollow tubular organs and other tissue lumens
|
US5843089A
(en)
*
|
1990-12-28 |
1998-12-01 |
Boston Scientific Corporation |
Stent lining
|
US5674192A
(en)
*
|
1990-12-28 |
1997-10-07 |
Boston Scientific Corporation |
Drug delivery
|
US6228844B1
(en)
|
1991-11-12 |
2001-05-08 |
Vical Incorporated |
Stimulating vascular growth by administration of DNA sequences encoding VEGF
|
US6706694B1
(en)
|
1990-03-21 |
2004-03-16 |
Vical Incorporated |
Expression of exogenous polynucleotide sequences in a vertebrate
|
US6410010B1
(en)
|
1992-10-13 |
2002-06-25 |
Board Of Regents, The University Of Texas System |
Recombinant P53 adenovirus compositions
|
CA2108144A1
(en)
|
1991-03-06 |
1992-09-07 |
Jack A. Roth |
Methods and compositions for the selective inhibition of gene expression
|
US5747469A
(en)
|
1991-03-06 |
1998-05-05 |
Board Of Regents, The University Of Texas System |
Methods and compositions comprising DNA damaging agents and p53
|
US6743623B2
(en)
*
|
1991-09-27 |
2004-06-01 |
Centre National De La Recherche Scientifique |
Viral recombinant vectors for expression in muscle cells
|
US5586982A
(en)
*
|
1992-04-10 |
1996-12-24 |
Abela; George S. |
Cell transfection apparatus and method
|
US6936025B1
(en)
|
1992-05-19 |
2005-08-30 |
Bacchus Vascular, Inc. |
Thrombolysis device
|
US5713848A
(en)
|
1993-05-19 |
1998-02-03 |
Dubrul; Will R. |
Vibrating catheter
|
US6806084B1
(en)
*
|
1992-06-04 |
2004-10-19 |
The Regents Of The University Of California |
Methods for compositions for in vivo gene delivery
|
US5646042A
(en)
*
|
1992-08-26 |
1997-07-08 |
Ribozyme Pharmaceuticals, Inc. |
C-myb targeted ribozymes
|
EP0746625B1
(de)
|
1992-11-09 |
2004-03-31 |
THE UNITED STATES GOVERNMENT as represented by THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Erzielbare vektorenpartikel
|
GB9223816D0
(en)
|
1992-11-13 |
1993-01-06 |
Medical Res Council |
Heat shock proteins and the treatment of tumours
|
WO1994011506A1
(en)
*
|
1992-11-18 |
1994-05-26 |
Arch Development Corporation |
Adenovirus-mediated gene transfer to cardiac and vascular smooth muscle
|
US5830461A
(en)
*
|
1992-11-25 |
1998-11-03 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Methods for promoting wound healing and treating transplant-associated vasculopathy
|
US5658565A
(en)
*
|
1994-06-24 |
1997-08-19 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Inducible nitric oxide synthase gene for treatment of disease
|
US5658780A
(en)
|
1992-12-07 |
1997-08-19 |
Ribozyme Pharmaceuticals, Inc. |
Rel a targeted ribozymes
|
AU6829994A
(en)
*
|
1993-05-10 |
1994-12-12 |
Regents Of The University Of Michigan, The |
Gene transfer into pancreatic and biliary epithelial cells
|
AU7019494A
(en)
*
|
1993-05-20 |
1994-12-20 |
Baylor College Of Medicine |
Genetic therapy for cardiovascular disease
|
WO1994027435A1
(en)
*
|
1993-06-01 |
1994-12-08 |
Life Technologies, Inc. |
Genetic immunization with cationic lipids
|
AU7404994A
(en)
*
|
1993-07-30 |
1995-02-28 |
Regents Of The University Of California, The |
Endocardial infusion catheter
|
US6682728B1
(en)
*
|
1993-10-13 |
2004-01-27 |
The United States Of America As Represented By The Department Of Health And Human Services |
Efficient and selective adenoviral-mediated gene transfer into vascular neointima
|
ES2077519B1
(es)
*
|
1993-11-22 |
1996-07-01 |
Fernandez De Lomana Euge Anaya |
Cateter intraaortico para perfusion y conservacion renal.
|
US5792106A
(en)
*
|
1993-12-02 |
1998-08-11 |
Scimed Life Systems, Inc. |
In situ stent forming catheter
|
US5409012A
(en)
*
|
1993-12-30 |
1995-04-25 |
Boston Scientific Corporation |
Sample collection using catheter with expandable member
|
CA2179029C
(en)
|
1993-12-30 |
2009-02-24 |
Philip W. Ingham |
Vertebrate embryonic pattern-inducing hedgehog-like proteins
|
DE4411402A1
(de)
*
|
1994-03-31 |
1995-10-05 |
Juergen Schrader |
DNA-Expressionsvektoren zur Verwendung in der gentherapeutischen Behandlung von Gefäßerkrankungen
|
WO1995027494A1
(en)
*
|
1994-04-11 |
1995-10-19 |
Sloan-Kettering Institute For Cancer Research |
DEFECTIVE HERPES AND DEFECTIVE ADENO-ASSOCIATED VIRUS VECTORS WITH p53 FOR THE TREATMENT OF CANCER
|
US6103890A
(en)
*
|
1994-05-18 |
2000-08-15 |
Ribozyme Pharmaceuticals, Inc. |
Enzymatic nucleic acids that cleave C-fos
|
US6150137A
(en)
|
1994-05-27 |
2000-11-21 |
Ariad Pharmaceuticals, Inc. |
Immunosuppressant target proteins
|
FR2723697B1
(fr)
*
|
1994-08-17 |
1996-09-20 |
Rhone Poulenc Rorer Sa |
Methode de traitement de la restenose par la therapie genique
|
NO180167C
(no)
*
|
1994-09-08 |
1997-02-26 |
Photocure As |
Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol
|
US5652225A
(en)
*
|
1994-10-04 |
1997-07-29 |
St. Elizabeth's Medical Center Of Boston, Inc. |
Methods and products for nucleic acid delivery
|
ATE198979T1
(de)
*
|
1994-10-12 |
2001-02-15 |
Focal Inc |
Zielgerichte verabreichung mittels biologisch abbaubarer polymere
|
US6911216B1
(en)
|
1994-10-12 |
2005-06-28 |
Genzyme Corporation |
Targeted delivery via biodegradable polymers
|
US5713861A
(en)
*
|
1994-10-17 |
1998-02-03 |
Vanarthos; William |
Trauma urethral catheter and method of using same
|
US5641665A
(en)
*
|
1994-11-28 |
1997-06-24 |
Vical Incorporated |
Plasmids suitable for IL-2 expression
|
US5948767A
(en)
*
|
1994-12-09 |
1999-09-07 |
Genzyme Corporation |
Cationic amphiphile/DNA complexes
|
WO1996020208A2
(de)
*
|
1994-12-28 |
1996-07-04 |
Max-Delbrück-Centrum für Molekulare Medizin |
Neues cholesterolderivat für den liposomalen gentransfer
|
US6818439B1
(en)
|
1994-12-30 |
2004-11-16 |
Chiron Corporation |
Methods for administration of recombinant gene delivery vehicles for treatment of hemophilia and other disorders
|
WO1996020731A1
(en)
*
|
1994-12-30 |
1996-07-11 |
Chiron Viagene, Inc. |
Direct administration of gene delivery vehicles at multiple sites
|
US6630455B1
(en)
|
1995-01-13 |
2003-10-07 |
Vanderbilt University |
Methods for inducing mucosal immune responses
|
WO1996026742A1
(en)
*
|
1995-02-28 |
1996-09-06 |
The Regents Of The University Of California |
Gene transfer-mediated angiogenesis therapy
|
US20030148968A1
(en)
*
|
1995-02-28 |
2003-08-07 |
Hammond H. Kirk |
Techniques and compositions for treating cardiovascular disease by in vivo gene delivery
|
US6210356B1
(en)
|
1998-08-05 |
2001-04-03 |
Ekos Corporation |
Ultrasound assembly for use with a catheter
|
US6176842B1
(en)
|
1995-03-08 |
2001-01-23 |
Ekos Corporation |
Ultrasound assembly for use with light activated drugs
|
US5837693A
(en)
*
|
1995-03-24 |
1998-11-17 |
The Regents Of The University Of California |
Intravenous hormone polypeptide delivery by salivary gland expression
|
US6531455B1
(en)
|
1995-03-24 |
2003-03-11 |
The Regents Of The University Of California |
Delivery of polynucleotides by secretory gland expression
|
US5885971A
(en)
*
|
1995-03-24 |
1999-03-23 |
The Regents Of The University Of California |
Gene therapy by secretory gland expression
|
US5766901A
(en)
*
|
1995-05-04 |
1998-06-16 |
The Board Of Trustees Of The Leland Stanford Junior University |
Apparatus and method for delivering a nucleotide into cell nuclei
|
US5922687A
(en)
*
|
1995-05-04 |
1999-07-13 |
Board Of Trustees Of The Leland Stanford Junior University |
Intracellular delivery of nucleic acids using pressure
|
US6322548B1
(en)
|
1995-05-10 |
2001-11-27 |
Eclipse Surgical Technologies |
Delivery catheter system for heart chamber
|
ATE226094T1
(de)
*
|
1995-05-16 |
2002-11-15 |
Karl Tryggvason |
Verfahren zur arzneistoffabgabe mittels gentherapie
|
US6638264B1
(en)
*
|
1995-05-16 |
2003-10-28 |
Biostratum Incorporation |
Perfusion apparatus and methods for pharmaceutical delivery
|
US5797870A
(en)
*
|
1995-06-07 |
1998-08-25 |
Indiana University Foundation |
Pericardial delivery of therapeutic and diagnostic agents
|
US5674198A
(en)
*
|
1995-06-23 |
1997-10-07 |
Cordis Corporation |
Tandem balloon catheter
|
US5725568A
(en)
*
|
1995-06-27 |
1998-03-10 |
Scimed Life Systems, Inc. |
Method and device for recanalizing and grafting arteries
|
US7011976B1
(en)
|
1997-03-03 |
2006-03-14 |
Calydon, Inc. |
Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof
|
PL185338B1
(pl)
*
|
1995-06-27 |
2003-04-30 |
Bavarian Nordic As |
Kapsułka otaczająca linię komórek pakujących produkujących cząsteczki retrowirusa, sposób otrzymywania kapsułki otaczającej linię komórek pakujących produkujących cząsteczki retrowirusa, zastosowanie kapsułki otaczającej linię komórek pakujących produkujących cząsteczki retrowirusa, sposób wytwarzania kompozycji farmaceutycznej oraz kompozycja farmaceutyczna
|
US6254862B1
(en)
|
1997-03-03 |
2001-07-03 |
Calydon, Inc. |
Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof
|
US6121246A
(en)
*
|
1995-10-20 |
2000-09-19 |
St. Elizabeth's Medical Center Of Boston, Inc. |
Method for treating ischemic tissue
|
US5837534A
(en)
*
|
1995-11-14 |
1998-11-17 |
The Board Of Regents Of The University Of Texas System |
Smooth muscle 22α promoter, gene transfer vectors containing the same, and method of use of the same to target gene expression in arterial smooth muscle cells
|
CZ296810B6
(cs)
*
|
1995-11-30 |
2006-06-14 |
Board Of Regents, The University Of Texas System |
Léciva pro lécbu nádoru
|
JP2000502682A
(ja)
*
|
1995-12-22 |
2000-03-07 |
ローカルメッド インコーポレイテッド |
血管新生を促進する成長因子の局所的血管内デリバリー
|
US5998384A
(en)
*
|
1996-01-26 |
1999-12-07 |
Hisamitsu Pharmaceutical Co., Inc. |
Endoscopic administration of an HSV-tk gene to treat digestive organ cancer
|
AU2112697A
(en)
*
|
1996-02-09 |
1997-08-28 |
Pi-Wan Cheng |
Receptor ligand-facilitated delivery of biologically active molecules
|
WO1997029701A1
(en)
|
1996-02-15 |
1997-08-21 |
Biosense Inc. |
Catheter based surgery
|
US6037332A
(en)
*
|
1996-02-20 |
2000-03-14 |
Emory University |
Method of urinary bladder instillation
|
US5866340A
(en)
*
|
1996-03-22 |
1999-02-02 |
Johns Hopkins University |
Selective expression of desired genes in cells expressing oncoproteins
|
US6777217B1
(en)
*
|
1996-03-26 |
2004-08-17 |
President And Fellows Of Harvard College |
Histone deacetylases, and uses related thereto
|
DE19620687A1
(de)
*
|
1996-05-22 |
1997-11-27 |
Centeon Pharma Gmbh |
Neuer adenoviraler Vektor für den Transfer humaner Gene in vivo
|
DE69736862T2
(de)
*
|
1996-07-17 |
2007-05-31 |
Medtronic, Inc., Minneapolis |
Abgabesystem zur Abgabe von genetischem Material an Herzgewebe
|
AU2437397A
(en)
|
1996-07-17 |
1998-02-09 |
Medtronic, Inc. |
System for enhancing cardiac signal sensing by cardiac pacemakers through genetic treatment
|
US6443974B1
(en)
*
|
1996-07-28 |
2002-09-03 |
Biosense, Inc. |
Electromagnetic cardiac biostimulation
|
US6225290B1
(en)
*
|
1996-09-19 |
2001-05-01 |
The Regents Of The University Of California |
Systemic gene therapy by intestinal cell transformation
|
US6335010B1
(en)
*
|
1996-11-08 |
2002-01-01 |
University Of California At San Diego |
Gene therapy in coronary angioplasty and bypass
|
US6797276B1
(en)
|
1996-11-14 |
2004-09-28 |
The United States Of America As Represented By The Secretary Of The Army |
Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response
|
US20060002949A1
(en)
|
1996-11-14 |
2006-01-05 |
Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. |
Transcutaneous immunization without heterologous adjuvant
|
US5980898A
(en)
|
1996-11-14 |
1999-11-09 |
The United States Of America As Represented By The U.S. Army Medical Research & Material Command |
Adjuvant for transcutaneous immunization
|
US6494861B1
(en)
|
1997-01-15 |
2002-12-17 |
Boston Scientific Corporation |
Drug delivery system
|
US5868719A
(en)
*
|
1997-01-15 |
1999-02-09 |
Boston Scientific Corporation |
Drug delivery balloon catheter device
|
DE69839007T2
(de)
*
|
1997-02-04 |
2009-01-22 |
Cook Urological Inc., Spencer |
Durch die bauchdecke einzuführender drainagekatheter
|
US5837283A
(en)
*
|
1997-03-12 |
1998-11-17 |
The Regents Of The University Of California |
Cationic lipid compositions targeting angiogenic endothelial cells
|
US7112338B2
(en)
*
|
1997-03-12 |
2006-09-26 |
The Regents Of The University Of California |
Cationic liposome delivery of taxanes to angiogenic blood vessels
|
ES2303726T3
(es)
*
|
1997-04-10 |
2008-08-16 |
University Of Southern California |
Proteinas modificadas que se fijan a componentes de la matriz extracelular.
|
DE69842225D1
(de)
|
1997-04-16 |
2011-05-26 |
Millennium Pharm Inc |
Zusammensetzung, umfassend einen Antikörper, der selektiv an ein cysteinreiches sekretiertes Protein (CRSP) bindet
|
US6582392B1
(en)
|
1998-05-01 |
2003-06-24 |
Ekos Corporation |
Ultrasound assembly for use with a catheter
|
WO1998048711A1
(en)
*
|
1997-05-01 |
1998-11-05 |
Ekos Corporation |
Ultrasound catheter
|
US6676626B1
(en)
*
|
1998-05-01 |
2004-01-13 |
Ekos Corporation |
Ultrasound assembly with increased efficacy
|
US6723063B1
(en)
|
1998-06-29 |
2004-04-20 |
Ekos Corporation |
Sheath for use with an ultrasound element
|
DE19726244C2
(de)
*
|
1997-06-20 |
2000-03-02 |
Mucos Pharma Gmbh & Co |
Verwendung proteolytischer Enzyme und Rutosid zur Vorbeugung bzw. Behandlung der Transplantatabstoßung
|
US6977074B2
(en)
|
1997-07-10 |
2005-12-20 |
Mannkind Corporation |
Method of inducing a CTL response
|
US6994851B1
(en)
*
|
1997-07-10 |
2006-02-07 |
Mannkind Corporation |
Method of inducing a CTL response
|
DE19729769A1
(de)
|
1997-07-11 |
1999-01-14 |
Cardiogene Gentherapeutische S |
Transfektionssystem, seine Herstellung und Verwendung in der somatischen Gentherapie
|
US6177272B1
(en)
*
|
1997-07-21 |
2001-01-23 |
The Regents Of The University Of Michigan |
Method for treating vascular proliferative diseases with p27 and fusions thereof
|
US20090239940A1
(en)
*
|
1997-07-22 |
2009-09-24 |
Del Monte Federica |
Treating heart failure and ventricular arrhythmias
|
WO1999006576A1
(en)
|
1997-08-04 |
1999-02-11 |
Calydon, Inc. |
A human glandular kallikrein enhancer, vectors comprising the enhancer and methods of use thereof
|
US6696423B1
(en)
|
1997-08-29 |
2004-02-24 |
Biogen, Inc. |
Methods and compositions for therapies using genes encoding secreted proteins such as interferon-beta
|
US6376471B1
(en)
|
1997-10-10 |
2002-04-23 |
Johns Hopkins University |
Gene delivery compositions and methods
|
AU1114699A
(en)
*
|
1997-10-24 |
1999-05-17 |
Children's Medical Center Corporation |
Methods for promoting cell transfection (in vivo)
|
US6610497B1
(en)
*
|
1997-12-11 |
2003-08-26 |
Millennium Pharmaceuticals, Inc. |
Angiotensin converting enzyme homolog and therapeutic and diagnostic uses therefor
|
US6251418B1
(en)
|
1997-12-18 |
2001-06-26 |
C.R. Bard, Inc. |
Systems and methods for local delivery of an agent
|
US6197324B1
(en)
|
1997-12-18 |
2001-03-06 |
C. R. Bard, Inc. |
System and methods for local delivery of an agent
|
WO1999033500A2
(en)
|
1997-12-31 |
1999-07-08 |
Pharmasonics, Inc. |
Methods, systems, and kits for intravascular nucleic acid delivery
|
US6794369B2
(en)
|
1997-12-31 |
2004-09-21 |
Pharmasonics |
Methods, systems, and kits for intravascular nucleic acid delivery
|
US6699231B1
(en)
|
1997-12-31 |
2004-03-02 |
Heartport, Inc. |
Methods and apparatus for perfusion of isolated tissue structure
|
US6221425B1
(en)
|
1998-01-30 |
2001-04-24 |
Advanced Cardiovascular Systems, Inc. |
Lubricious hydrophilic coating for an intracorporeal medical device
|
US20030129750A1
(en)
*
|
1998-02-05 |
2003-07-10 |
Yitzhack Schwartz |
Homing of donor cells to a target zone in tissue using active therapeutics or substances
|
US20030113303A1
(en)
*
|
1998-02-05 |
2003-06-19 |
Yitzhack Schwartz |
Homing of embryonic stem cells to a target zone in tissue using active therapeutics or substances
|
US7749215B1
(en)
*
|
1998-02-05 |
2010-07-06 |
Biosense, Inc. |
Intracardiac cell delivery and cell transplantation
|
US6309370B1
(en)
|
1998-02-05 |
2001-10-30 |
Biosense, Inc. |
Intracardiac drug delivery
|
AU767662B2
(en)
|
1998-02-06 |
2003-11-20 |
Collateral Therapeutics, Inc. |
Variants of the angiogenic factor vascular endothelial cell growth factor: VEGF
|
US6148222A
(en)
*
|
1998-07-10 |
2000-11-14 |
Cardiocommand, Inc. |
Esophageal catheters and method of use
|
US7700353B2
(en)
*
|
1998-07-22 |
2010-04-20 |
E-P Therapeutics, Inc. |
Compositions and methods for inducing apoptosis in tumor cells
|
EP1736547A1
(de)
*
|
1998-08-26 |
2006-12-27 |
Stürzl, Michael, Prof. Dr. rer. nat |
Guanylat-bindendes Protein (GBP-1) als Inhibitor der Endothelzell-Proliferation
|
US6312402B1
(en)
|
1998-09-24 |
2001-11-06 |
Ekos Corporation |
Ultrasound catheter for improving blood flow to the heart
|
US6689121B1
(en)
|
1998-09-24 |
2004-02-10 |
C. R. Bard, Inc. |
Systems and methods for treating ischemia
|
US6135976A
(en)
*
|
1998-09-25 |
2000-10-24 |
Ekos Corporation |
Method, device and kit for performing gene therapy
|
US6251079B1
(en)
|
1998-09-30 |
2001-06-26 |
C. R. Bard, Inc. |
Transthoracic drug delivery device
|
US20030027998A1
(en)
*
|
1998-10-30 |
2003-02-06 |
Holtzman Douglas A. |
Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
|
US20060205034A1
(en)
*
|
1998-10-30 |
2006-09-14 |
Millennium Pharmaceuticals, Inc. |
Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
|
JP4854853B2
(ja)
|
1998-11-12 |
2012-01-18 |
ライフ テクノロジーズ コーポレーション |
トランスフェクション薬剤
|
DE69917484T2
(de)
*
|
1998-12-14 |
2005-05-12 |
Tre Esse Progettazione Biomedica S.R.L. |
Kathetersystem zur durchführung einer intramyokardialen therapeutischen behandlung
|
US7122019B1
(en)
|
2000-11-28 |
2006-10-17 |
Flowmedica Inc. |
Intra-aortic renal drug delivery catheter
|
US7329236B2
(en)
*
|
1999-01-11 |
2008-02-12 |
Flowmedica, Inc. |
Intra-aortic renal drug delivery catheter
|
US7780628B1
(en)
|
1999-01-11 |
2010-08-24 |
Angiodynamics, Inc. |
Apparatus and methods for treating congestive heart disease
|
US6749598B1
(en)
|
1999-01-11 |
2004-06-15 |
Flowmedica, Inc. |
Apparatus and methods for treating congestive heart disease
|
US7481803B2
(en)
*
|
2000-11-28 |
2009-01-27 |
Flowmedica, Inc. |
Intra-aortic renal drug delivery catheter
|
US6695830B2
(en)
*
|
1999-01-15 |
2004-02-24 |
Scimed Life Systems, Inc. |
Method for delivering medication into an arterial wall for prevention of restenosis
|
DE19956568A1
(de)
*
|
1999-01-30 |
2000-08-17 |
Roland Kreutzer |
Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens
|
EP2301947A3
(de)
|
1999-02-26 |
2011-11-23 |
Millennium Pharmaceuticals, Inc. |
Sekretierte Proteine und Verwendungen dafür
|
IL139321A0
(en)
|
1999-03-03 |
2001-11-25 |
Biogen Inc |
Methods and compositions for modulating lipid metabolism
|
JP4932086B2
(ja)
*
|
1999-04-08 |
2012-05-16 |
インターセル ユーエスエイ、インコーポレイテッド |
経皮的免疫のための乾燥製剤
|
US6224566B1
(en)
|
1999-05-04 |
2001-05-01 |
Cardiodyne, Inc. |
Method and devices for creating a trap for confining therapeutic drugs and/or genes in the myocardium
|
US6565528B1
(en)
|
1999-05-07 |
2003-05-20 |
Scimed Life Systems, Inc. |
Apparatus and method for delivering therapeutic and diagnostic agents
|
US20040229779A1
(en)
*
|
1999-05-14 |
2004-11-18 |
Ramesh Kekuda |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
US20040023874A1
(en)
*
|
2002-03-15 |
2004-02-05 |
Burgess Catherine E. |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
US6974684B2
(en)
*
|
2001-08-08 |
2005-12-13 |
Curagen Corporation |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
US6774120B1
(en)
*
|
1999-06-01 |
2004-08-10 |
Sarah Ferber |
Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues
|
US8778899B2
(en)
*
|
1999-06-01 |
2014-07-15 |
Sarah Ferber |
Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues
|
WO2000072908A1
(en)
*
|
1999-06-02 |
2000-12-07 |
Microheart, Inc. |
Devices and methods for delivering a drug
|
US7147633B2
(en)
*
|
1999-06-02 |
2006-12-12 |
Boston Scientific Scimed, Inc. |
Method and apparatus for treatment of atrial fibrillation
|
US20040067490A1
(en)
*
|
2001-09-07 |
2004-04-08 |
Mei Zhong |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
US7291714B1
(en)
|
1999-06-30 |
2007-11-06 |
Millennium Pharmaceuticals, Inc. |
Glycoprotein VI and uses thereof
|
US7001766B2
(en)
*
|
1999-07-20 |
2006-02-21 |
Curagen Corporation |
Nucleic acid sequences encoding human angiopoietin-like polypeptides
|
WO2001007654A1
(en)
*
|
1999-07-22 |
2001-02-01 |
The General Hospital Corporation |
Method for identifying compounds which modulate circadian rhythm
|
WO2001006989A2
(en)
*
|
1999-07-27 |
2001-02-01 |
Abgenix, Inc. |
Methods and compositions for inhibiting polypeptide accumulation associated with neurological disorders
|
US6855160B1
(en)
|
1999-08-04 |
2005-02-15 |
C. R. Bard, Inc. |
Implant and agent delivery device
|
US6808710B1
(en)
|
1999-08-23 |
2004-10-26 |
Genetics Institute, Inc. |
Downmodulating an immune response with multivalent antibodies to PD-1
|
US6429303B1
(en)
|
1999-09-03 |
2002-08-06 |
Curagen Corporation |
Nucleic acids encoding members of the human B lymphocyte activation antigen B7 family and methods of using the same
|
WO2001017508A1
(en)
*
|
1999-09-09 |
2001-03-15 |
The Regents Of The University Of California |
Cationic liposome delivery of taxanes to angiogenic blood vessels
|
DK2363142T3
(en)
*
|
1999-09-24 |
2015-04-20 |
Proteon Therapeutics Inc |
Elastase for opening the closed biological channels
|
US6855806B1
(en)
*
|
1999-10-15 |
2005-02-15 |
Curagen Corporation |
Thymosin beta 10-like proteins and nucleic acids encoding same
|
US8808272B2
(en)
*
|
1999-10-28 |
2014-08-19 |
Boston Scientific Scimed, Inc. |
Biocompatible medical devices
|
US6759520B1
(en)
|
1999-10-28 |
2004-07-06 |
The New England Medical Center Hospitals, Inc. |
Chimeric analgesic peptides
|
DE10100586C1
(de)
*
|
2001-01-09 |
2002-04-11 |
Ribopharma Ag |
Verfahren zur Hemmung der Expression eines Ziegens
|
US6951839B1
(en)
|
1999-11-30 |
2005-10-04 |
Curis, Inc. |
Methods and compositions for regulating lymphocyte activity
|
US8168178B2
(en)
*
|
1999-11-30 |
2012-05-01 |
Curis, Inc. |
Methods and compositions for regulating lymphocyte activity
|
WO2001064882A2
(en)
|
2000-02-29 |
2001-09-07 |
Millennium Pharmaceuticals, Inc. |
1983, 52881, 2398, 45449, 50289, and 52872, g protein-coupled receptors and uses therefor
|
KR100748297B1
(ko)
|
2000-02-29 |
2007-08-09 |
알콘, 인코퍼레이티드 |
녹내장의 진단법 및 치료법
|
US20030129724A1
(en)
|
2000-03-03 |
2003-07-10 |
Grozinger Christina M. |
Class II human histone deacetylases, and uses related thereto
|
EP1261712B1
(de)
*
|
2000-03-03 |
2006-12-13 |
Curagen Corporation |
Fctrx genannte proteine und dafür kodierende nuklein säure
|
US7517352B2
(en)
|
2000-04-07 |
2009-04-14 |
Bacchus Vascular, Inc. |
Devices for percutaneous remote endarterectomy
|
EP1276849A4
(de)
|
2000-04-12 |
2004-06-09 |
Human Genome Sciences Inc |
Albumin fusionsproteine
|
US6864229B2
(en)
|
2000-04-21 |
2005-03-08 |
New England Medical Center Hospitals, Inc. |
G protein coupled receptor (GPCR) agonists and antagonists and methods of activating and inhibiting GPCR using the same
|
ES2316446T3
(es)
|
2000-04-29 |
2009-04-16 |
University Of Iowa Research Foundation |
Diagnostico y terapeutica para trastornos relacionados con la degeneracion macular.
|
US20030219786A1
(en)
*
|
2000-08-11 |
2003-11-27 |
Applied Research Systems Ars Holding N.V. |
Novel glycoproteins and methods of use thereof
|
US20040005554A1
(en)
*
|
2000-05-08 |
2004-01-08 |
Tayar Nabil El |
Novel glycoproteins and methods of use thereof
|
US7232421B1
(en)
|
2000-05-12 |
2007-06-19 |
C. R. Bard, Inc. |
Agent delivery systems
|
EP1714661A3
(de)
|
2000-05-19 |
2012-03-14 |
The Center for Blood Research, INC. |
Verfahren zur Diagnose und Behandlung von hämostatischen Störungen durch Modulation der P-Selectin Aktivität
|
US20050048614A1
(en)
*
|
2000-06-13 |
2005-03-03 |
Children's Medical Center Corporation |
Biosynthetic oncolytic molecules and uses therefor
|
US20040034193A1
(en)
*
|
2001-06-13 |
2004-02-19 |
Samy Ashkar |
Biosynthetic oncolytic molecules and uses therefor
|
US20040023259A1
(en)
*
|
2000-07-26 |
2004-02-05 |
Luca Rastelli |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
JP2004505620A
(ja)
*
|
2000-08-03 |
2004-02-26 |
ザ ユニバーシティ オブ ユタ リサーチ ファウンデーション |
動静脈特性の操作
|
US20020160952A1
(en)
*
|
2000-08-18 |
2002-10-31 |
Kazantsev Aleksey G. |
Inhibition of protein-protein interaction
|
US6740331B1
(en)
*
|
2000-08-25 |
2004-05-25 |
Global Gene Therapies, Inc. |
Apparatus for the delivery of drugs or gene therapy into a patient's vasculature and methods of use
|
US7651696B2
(en)
*
|
2000-08-25 |
2010-01-26 |
Nexeon Medical Systems, Inc. |
Implantable device for treating disease states and methods of using same
|
JP5113314B2
(ja)
|
2000-09-01 |
2013-01-09 |
ザ センター フォー ブラッド リサーチ インク |
所望のコンホメーションで安定させた改変ポリペプチド及び該ポリペプチドの作製方法
|
UA83458C2
(uk)
|
2000-09-18 |
2008-07-25 |
Байоджен Айдек Ма Інк. |
Виділений поліпептид baff-r (рецептор фактора активації в-клітин сімейства tnf)
|
MXPA03002413A
(es)
*
|
2000-09-20 |
2003-06-19 |
Amgen Inc |
Moleculas tipo b7 y uso de las mismas.
|
DE60140903D1
(de)
|
2000-10-18 |
2010-02-04 |
Brigham & Womens Hospital |
E-selectin/l-selectin-liganden-polypeptide hämatopoetischer zellen und verfahren zu deren verwendung
|
BR0115728A
(pt)
|
2000-11-28 |
2003-09-23 |
Wyeth Corp |
Análise da expressão de ácidos nucléicos kiaa e polipeptìdeos úteis no diagnóstico e tratamento de cáncer de próstata
|
NZ526708A
(en)
|
2000-11-28 |
2005-07-29 |
Wyeth Corp |
Expression analysis of FKBP nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
|
WO2002044394A2
(en)
*
|
2000-11-29 |
2002-06-06 |
University Of Southern California |
Targetet retoviral vectors for cancer immunotherapy
|
US7247704B2
(en)
|
2000-12-18 |
2007-07-24 |
Arriva Pharmaceuticals, Inc. |
Multifunctional protease inhibitors and their use in treatment of disease
|
US7423142B2
(en)
*
|
2001-01-09 |
2008-09-09 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of anti-apoptotic genes
|
US7767802B2
(en)
*
|
2001-01-09 |
2010-08-03 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of anti-apoptotic genes
|
US6964849B2
(en)
|
2001-01-11 |
2005-11-15 |
Curagen Corporation |
Proteins and nucleic acids encoding same
|
US20040043928A1
(en)
*
|
2001-08-02 |
2004-03-04 |
Ramesh Kekuda |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
US7015012B2
(en)
*
|
2001-02-09 |
2006-03-21 |
Massachusetts Institute Of Technology |
Methods of identifying agents that mediate polypeptide aggregation
|
WO2002064162A2
(en)
|
2001-02-13 |
2002-08-22 |
Government Of The United States, As Represented By The Secretary Of The Army |
Vaccine for transcutaneous immunization
|
US7491394B2
(en)
|
2001-02-15 |
2009-02-17 |
The Board Of Trustees Of The University Of Illinois |
Cytotoxic factors for modulating cell death
|
US8981061B2
(en)
|
2001-03-20 |
2015-03-17 |
Novo Nordisk A/S |
Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof
|
US20090081199A1
(en)
*
|
2001-03-20 |
2009-03-26 |
Bioxell S.P.A. |
Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
|
US8231878B2
(en)
*
|
2001-03-20 |
2012-07-31 |
Cosmo Research & Development S.P.A. |
Receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
|
CA2342376C
(en)
*
|
2001-03-20 |
2013-11-12 |
Marco Colonna |
A receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
|
WO2002079499A1
(en)
|
2001-04-02 |
2002-10-10 |
Wyeth |
Pd-1, a receptor for b7-4, and uses therefor
|
US20030148298A1
(en)
*
|
2001-04-03 |
2003-08-07 |
O''toole Margot |
Methods for diagnosing and treating systemic lupus erythematosus disease and compositions thereof
|
US6820011B2
(en)
*
|
2001-04-11 |
2004-11-16 |
The Regents Of The University Of Colorado |
Three-dimensional structure of complement receptor type 2 and uses thereof
|
MXPA03009415A
(es)
|
2001-04-16 |
2004-01-29 |
Wyeth Corp |
ESTRUCTURAS NOVEDOSAS DE LECTURA ABIERTA DE STREPTOCOCCUS PNEUMONIAE QUE CODIFICAN ANTIGENOS DE POLIPePTIDOS Y USOS DE LAS MISMAS.
|
US20030017159A1
(en)
*
|
2001-05-02 |
2003-01-23 |
Jerome Ritz |
Immunogenic tumor antigens: nucleic acids and polypeptides encoding the same and methods of use thereof
|
US7244853B2
(en)
*
|
2001-05-09 |
2007-07-17 |
President And Fellows Of Harvard College |
Dioxanes and uses thereof
|
KR100635703B1
(ko)
|
2001-06-07 |
2006-10-17 |
케모센트릭스, 인크. |
세포 이동성 검사
|
JP2004537297A
(ja)
*
|
2001-06-07 |
2004-12-16 |
ワイス |
G−タンパク質結合レセプターおよびその使用
|
JP2005500032A
(ja)
*
|
2001-06-15 |
2005-01-06 |
インターリューキン ジェネティックス インコーポレイテッド |
老化関連症状の早期発現を検出および治療する方法
|
US20040236377A1
(en)
*
|
2001-07-02 |
2004-11-25 |
Medtronic, Inc. |
System and method for enhancing cardiac signal sensing by cardiac pacemakers through genetic treatment
|
US20040029790A1
(en)
*
|
2001-07-05 |
2004-02-12 |
Meera Patturajan |
Novel human proteins, polynucleotides encoding them and methods of using the same
|
US20030129613A1
(en)
*
|
2001-07-05 |
2003-07-10 |
Fernandes Elma R. |
Novel human proteins and polynucleotides encoding them
|
US20030087274A1
(en)
*
|
2001-07-05 |
2003-05-08 |
Anderson David W. |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
EP1900815B1
(de)
|
2001-07-12 |
2016-09-07 |
University of Massachusetts |
In-vivo-Herstellung kleiner interferierender und Genverstummung vermittelnder RNAs
|
CA2921821A1
(en)
|
2001-07-12 |
2003-01-23 |
University Of Massachusetts |
In vivo production of small interfering rnas that mediate gene silencing
|
US20040030096A1
(en)
*
|
2001-08-02 |
2004-02-12 |
Linda Gorman |
Novel human proteins, polynucleotides encoding them and methods of using the same
|
WO2003015615A2
(en)
|
2001-08-15 |
2003-02-27 |
Brown University Research Foundation |
Treatment of muscular dystrophies and related disorders
|
US20040142325A1
(en)
*
|
2001-09-14 |
2004-07-22 |
Liat Mintz |
Methods and systems for annotating biomolecular sequences
|
US20070082337A1
(en)
*
|
2004-01-27 |
2007-04-12 |
Compugen Ltd. |
Methods of identifying putative gene products by interspecies sequence comparison and biomolecular sequences uncovered thereby
|
US7981863B2
(en)
|
2001-09-19 |
2011-07-19 |
Neuronova Ab |
Treatment of Parkinson's disease with PDGF
|
JP2005534279A
(ja)
|
2001-09-28 |
2005-11-17 |
ブリガム ヤング ユニバーシティ |
新規なシクロオキシゲナーゼ変異体とその使用方法
|
US6808518B2
(en)
|
2001-09-28 |
2004-10-26 |
Ethicon, Inc. |
Methods and devices for treating diseased blood vessels
|
ES2396964T3
(es)
*
|
2001-10-01 |
2013-03-01 |
Matrizyme Pharma Corporation |
Uso de colagenasa para facilitar el cruce con alambre de guia de oclusiones arteriales crónicas
|
US20030215460A1
(en)
*
|
2002-05-07 |
2003-11-20 |
Schall Thomas J. |
Methods and compositions for inducing an immune response
|
US20030096260A1
(en)
*
|
2001-10-09 |
2003-05-22 |
Zhenhua Miao |
Compositions useful as ligands for the formyl peptide receptor like 1 receptor and methods of use thereof
|
US20030199442A1
(en)
*
|
2001-10-09 |
2003-10-23 |
Alsobrook John P. |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
US7745418B2
(en)
*
|
2001-10-12 |
2010-06-29 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting viral replication
|
US7384407B2
(en)
*
|
2001-12-03 |
2008-06-10 |
Ekos Corporation |
Small vessel ultrasound catheter
|
EP1453425B1
(de)
|
2001-12-03 |
2006-03-08 |
Ekos Corporation |
Katheter mit mehreren ultraschall-abstrahlenden teilen
|
US7141044B2
(en)
|
2001-12-11 |
2006-11-28 |
Ekos Corporation |
Alternate site gene therapy
|
US20030170691A1
(en)
*
|
2001-12-19 |
2003-09-11 |
Millennium Pharmaceuticals, Inc. |
Human diacylglycerol acyltransferase 2 (DGAT2) family members and uses therefor
|
EP2277889B1
(de)
|
2001-12-21 |
2014-07-09 |
Human Genome Sciences, Inc. |
Fusionsproteine von Albumin und Interferon beta
|
US6939374B2
(en)
*
|
2001-12-21 |
2005-09-06 |
Scimed Life Systems, Inc. |
Stents, stenting systems, and related methods for agent delivery
|
KR20040089608A
(ko)
|
2002-02-07 |
2004-10-21 |
델타 바이오테크놀로지 리미티드 |
Hiv 억제 단백질
|
US20040068189A1
(en)
|
2002-02-28 |
2004-04-08 |
Wilson Richard R. |
Ultrasound catheter with embedded conductors
|
US7153685B2
(en)
*
|
2002-03-11 |
2006-12-26 |
The Board Of Trustees Of The University Of Illinois |
Tamoxifen and 4-hydroxytamoxifen-activated system for regulated production of proteins in eukaryotic cells
|
US8226629B1
(en)
|
2002-04-01 |
2012-07-24 |
Ekos Corporation |
Ultrasonic catheter power control
|
CA2483476A1
(en)
*
|
2002-04-22 |
2003-10-30 |
Absorber, Ab |
Fusion polypeptides and methods for inhibiting microbial adhesion
|
EP2392659B1
(de)
|
2002-06-17 |
2015-01-14 |
Thrasos Innovation, Inc. |
TDF-zugehörige Einzeldomänenverbindungen und Analoge davon
|
CA2491320A1
(en)
*
|
2002-07-15 |
2004-01-22 |
Wyeth |
Methods and compositions for modulating t helper (th) cell development and function
|
CA2496272A1
(en)
|
2002-08-20 |
2004-03-04 |
Millennium Pharmaceuticals, Inc. |
Integrin b6 markers for compositions, kits, and methods for identification, assessment, prevention and therapy of cervical cancer
|
WO2004032791A2
(en)
|
2002-09-20 |
2004-04-22 |
Flowmedica, Inc. |
Method and apparatus for selective material delivery via an intra-renal catheter
|
JP2006513809A
(ja)
|
2002-09-20 |
2006-04-27 |
フローメディカ,インコーポレイテッド |
送達シースを通して大動脈内カテーテルを挿入するための装置および方法
|
US20050197624A1
(en)
|
2004-03-04 |
2005-09-08 |
Flowmedica, Inc. |
Sheath for use in peripheral interventions
|
US7993325B2
(en)
|
2002-09-20 |
2011-08-09 |
Angio Dynamics, Inc. |
Renal infusion systems and methods
|
US7585836B2
(en)
|
2004-05-14 |
2009-09-08 |
Goodson Iv Harry Burt |
Bi-lateral local renal delivery for treating congestive heart failure and for BNP therapy
|
US7063679B2
(en)
*
|
2002-09-20 |
2006-06-20 |
Flowmedica, Inc. |
Intra-aortic renal delivery catheter
|
WO2004030718A2
(en)
*
|
2002-09-20 |
2004-04-15 |
Flowmedica, Inc. |
Method and apparatus for intra aortic substance delivery to a branch vessel
|
US6921371B2
(en)
|
2002-10-14 |
2005-07-26 |
Ekos Corporation |
Ultrasound radiating members for catheter
|
US20050026859A1
(en)
*
|
2002-11-12 |
2005-02-03 |
John Hilfinger |
Methods and compositions of gene delivery agents for systemic and local therapy
|
US20080026077A1
(en)
*
|
2002-11-12 |
2008-01-31 |
John Hilfinger |
Methods and compositions of gene delivery agents for systemic and local therapy
|
EP2292259A3
(de)
*
|
2002-11-15 |
2011-03-23 |
MUSC Foundation For Research Development |
Komplement-Modulatoren für Komplement-Rezeptor 2
|
US20050037011A1
(en)
*
|
2002-11-21 |
2005-02-17 |
Jones Stephen N. |
Diagnosing and treating hematopoietic cancers
|
EP2112229A3
(de)
|
2002-11-25 |
2009-12-02 |
Sequenom, Inc. |
Verfahren zum Identifizieren des Brustkrebsrisikos und zugehörige Behandlungen
|
US7771372B2
(en)
|
2003-01-03 |
2010-08-10 |
Ekos Corporation |
Ultrasonic catheter with axial energy field
|
AU2004213050B2
(en)
*
|
2003-02-20 |
2010-09-09 |
Proteon Therapeutics, Inc. |
Methods for the treatment and prevention of diseases of biological conduits
|
US20050233342A1
(en)
*
|
2003-03-07 |
2005-10-20 |
Muthiah Manoharan |
Methods of preventing off-target gene silencing
|
US20070179100A1
(en)
*
|
2003-04-09 |
2007-08-02 |
Muthiah Manoharan |
Protected monomers
|
US7851615B2
(en)
*
|
2003-04-17 |
2010-12-14 |
Alnylam Pharmaceuticals, Inc. |
Lipophilic conjugated iRNA agents
|
EP1625138A4
(de)
|
2003-04-17 |
2010-06-23 |
Alnylam Pharmaceuticals Inc |
Geschützte monomere
|
US7723509B2
(en)
|
2003-04-17 |
2010-05-25 |
Alnylam Pharmaceuticals |
IRNA agents with biocleavable tethers
|
US8796436B2
(en)
|
2003-04-17 |
2014-08-05 |
Alnylam Pharmaceuticals, Inc. |
Modified iRNA agents
|
EP2669377A3
(de)
*
|
2003-04-17 |
2015-10-14 |
Alnylam Pharmaceuticals Inc. |
Modifizierte iRNA-Wirkstoffe
|
US8017762B2
(en)
*
|
2003-04-17 |
2011-09-13 |
Alnylam Pharmaceuticals, Inc. |
Modified iRNA agents
|
US20090123428A1
(en)
*
|
2003-04-21 |
2009-05-14 |
Hall Frederick L |
Pathotropic targeted gene delivery system for cancer and other disorders
|
ES2366617T3
(es)
*
|
2003-04-21 |
2011-10-21 |
Epeius Biotechnologies Corporation |
Métodos y composiciones para el tratamiento de transtornos.
|
US20070178066A1
(en)
|
2003-04-21 |
2007-08-02 |
Hall Frederick L |
Pathotropic targeted gene delivery system for cancer and other disorders
|
EP1619995A2
(de)
*
|
2003-04-22 |
2006-02-01 |
Ekos Corporation |
Ultraschallverstärkter zentralvenöser katheter
|
JP2006526464A
(ja)
|
2003-06-05 |
2006-11-24 |
フローメディカ,インコーポレイテッド |
分枝した身体管腔において両側介入または診断を行うためのシステムおよび方法
|
CA2542232A1
(en)
|
2003-06-09 |
2005-01-20 |
Alnylam Pharmaceuticals, Inc. |
Method for treating neurodegenerative disease by inhibiting alpha-synuclein
|
US7595306B2
(en)
*
|
2003-06-09 |
2009-09-29 |
Alnylam Pharmaceuticals Inc |
Method of treating neurodegenerative disease
|
US20060134287A1
(en)
*
|
2003-08-20 |
2006-06-22 |
Vimini Robert J |
Packaging and cooking bag and method for packaging and preparing a meat product
|
US7354734B2
(en)
*
|
2003-08-25 |
2008-04-08 |
Funzyme Biotechnologies Sa |
Fungal proteins and nucleic acids encoding same
|
WO2005023292A1
(en)
|
2003-09-03 |
2005-03-17 |
The General Hospital Corporation |
Methods of treating restenosis
|
WO2005027980A1
(en)
*
|
2003-09-12 |
2005-03-31 |
University Of Massachusetts |
Rna interference for the treatment of gain-of-function disorders
|
US8680063B2
(en)
|
2003-09-12 |
2014-03-25 |
University Of Massachusetts |
RNA interference for the treatment of gain-of-function disorders
|
US20050059999A1
(en)
*
|
2003-09-15 |
2005-03-17 |
Mongeon Luc R. |
Delivering genetic material to a stimulation site
|
EP1670350A4
(de)
|
2003-10-07 |
2008-02-13 |
Millennium Pharm Inc |
Nukleinsäuremoleküle und proteine für die identifizierung, beurteilung, prävention und behandlung von ovarialkrebs
|
EP1677735B1
(de)
|
2003-10-17 |
2014-07-23 |
Joslin Diabetes Center, Inc. |
Verfahren und zusammensetzungen zur modulierung der adipozyten-funktion
|
US20050125914A1
(en)
*
|
2003-11-18 |
2005-06-16 |
Gerard Malle |
Hair shaping composition comprising at least one- non-hydroxide base
|
WO2005051206A1
(en)
|
2003-11-21 |
2005-06-09 |
Vnus Medical Technologies, Inc. |
Method and apparatus for treating a carotid artery
|
CA2487098A1
(en)
*
|
2003-12-22 |
2005-06-22 |
F. Hoffmann-La Roche Ag |
Novel targets for obesity from fat tissue
|
CA2487107A1
(en)
*
|
2003-12-22 |
2005-06-22 |
F. Hoffmann-La Roche Ag |
Novel targets for obesity from skeletal muscle
|
EP1711206A2
(de)
*
|
2004-01-26 |
2006-10-18 |
ChemoCentryx Inc |
Zusammensetzungen und verfahren zur verwendung von w-peptiden
|
US20070087986A1
(en)
*
|
2004-01-26 |
2007-04-19 |
Brett Premack |
Compositions and methods for enhancing immunity by chemoattractant adjuvants
|
US20060147946A1
(en)
*
|
2004-01-27 |
2006-07-06 |
Pinchas Akiva |
Novel calcium channel variants and methods of use thereof
|
US8404747B2
(en)
*
|
2004-03-05 |
2013-03-26 |
The General Hospital Corporation |
Compositions and methods for modulating interaction between polypeptides
|
AU2005222902B2
(en)
*
|
2004-03-12 |
2010-06-10 |
Alnylam Pharmaceuticals, Inc. |
iRNA agents targeting VEGF
|
GB0406728D0
(en)
*
|
2004-03-25 |
2004-04-28 |
Hydrodynamic Gene Delivery Ltd |
Gene therapy
|
CA2561565C
(en)
*
|
2004-04-08 |
2013-11-26 |
Sangamo Biosciences, Inc. |
Methods for repression of phospholamban gene and modulating cardiac contractility
|
EP1732614B1
(de)
*
|
2004-04-08 |
2008-12-24 |
Sangamo Biosciences Inc. |
Zusammensetzungen zur behandlung von neuropathischen und neurodegenerativen erkrankungen
|
EP1789453A2
(de)
*
|
2004-05-18 |
2007-05-30 |
Genentech, Inc. |
Haupthüllproteinvarianten des m13-virus zur c-terminalen und bi-terminalen anzeige eines heterologen proteins
|
RU2006138704A
(ru)
*
|
2004-05-19 |
2008-06-27 |
Вайет (Us) |
Модуляция производства иммуноглобулина и атопические расстройства
|
US7875275B2
(en)
*
|
2004-06-16 |
2011-01-25 |
The General Hospital Corporation |
Use of Bridge-1 and activators and inhibitors thereof in the treatment of insulin deficiency and diabetes
|
CA2571218C
(en)
|
2004-06-17 |
2015-11-03 |
William D. Carlson |
Tdf-related compounds and analogs thereof
|
US7342093B2
(en)
|
2004-07-23 |
2008-03-11 |
University Of Massachusetts |
Compounds that inhibit Hsp90 protein-protein interactions with IAP proteins
|
US7846438B2
(en)
|
2004-08-03 |
2010-12-07 |
Biogen Idec Ma Inc. |
Methods of promoting neurite outgrowth with soluble TAJ polypeptides
|
US20060051338A1
(en)
|
2004-08-20 |
2006-03-09 |
New York University |
Inhibition of mitogen-activated protein kinases in cardiovascular disease
|
EP2093297A3
(de)
|
2004-09-07 |
2009-11-18 |
Telethon Institute for Child Health Research |
Wirkstoffe zur Behandlung oder Vorbeugung einer allergischen Störung
|
EP2982754A1
(de)
|
2004-09-24 |
2016-02-10 |
Alnylam Pharmaceuticals, Inc. |
Rnai-modulation von apob und verwendungen davon
|
US20060069323A1
(en)
*
|
2004-09-24 |
2006-03-30 |
Flowmedica, Inc. |
Systems and methods for bi-lateral guidewire cannulation of branched body lumens
|
JP2008521401A
(ja)
*
|
2004-11-24 |
2008-06-26 |
アルナイラム ファーマシューティカルズ インコーポレイテッド |
BCR−ABL融合遺伝子のRNAi調節およびその使用方法
|
GB0426146D0
(en)
|
2004-11-29 |
2004-12-29 |
Bioxell Spa |
Therapeutic peptides and method
|
JP2008521575A
(ja)
*
|
2004-12-01 |
2008-06-26 |
ジェンザイム・コーポレイション |
肝臓を標的とした遺伝物質の送達方法
|
US20060154285A1
(en)
*
|
2004-12-29 |
2006-07-13 |
Robishaw Janet D |
Zebrafish heterotrimer G-protein gamma 2 subunit (GNG2)
|
EP1848698B1
(de)
|
2005-01-25 |
2013-03-13 |
Prolexys Pharmaceuticals, Inc. |
Chinoxalinderivate als wirkstoffe gegen tumore
|
CA2590338A1
(en)
|
2005-01-25 |
2006-08-03 |
Five Prime Therapeutics, Inc. |
Compositions and methods for treating cardiac conditions
|
CA2937005A1
(en)
|
2005-03-22 |
2006-09-28 |
President And Fellows Of Harvard College |
Treatment of protein degradation disorders
|
PL1899364T3
(pl)
|
2005-05-17 |
2020-08-24 |
University Of Connecticut |
Kompozycje i sposoby immunomodulacji w organizmie
|
US20060281670A1
(en)
*
|
2005-06-10 |
2006-12-14 |
Wisconsin Alumni Research Foundation (Warf) |
Compositions and methods for modulating angiogenesis
|
JP2008543449A
(ja)
*
|
2005-06-17 |
2008-12-04 |
アボット・ラボラトリーズ |
変性脊椎疾患の改良型治療方法
|
CA2790675C
(en)
|
2005-07-19 |
2016-12-20 |
Stemgen S.P.A. |
Inhibition of the tumorigenic potential of tumor stem cells by lif and bmps
|
EP2230305A1
(de)
*
|
2005-07-21 |
2010-09-22 |
Alnylam Pharmaceuticals Inc. |
Rnai-Modulation des Rho-a-Gens und dessen Verwendungen
|
WO2007018318A1
(ja)
*
|
2005-08-10 |
2007-02-15 |
National University Corporation Kanazawa University |
小脳星状細胞及び/又は籠細胞特異的な遺伝子発現方法
|
WO2007022470A2
(en)
*
|
2005-08-18 |
2007-02-22 |
Alnylam Pharmaceuticals, Inc. |
Methods and compositions for treating neurological disease
|
WO2007024589A2
(en)
*
|
2005-08-24 |
2007-03-01 |
The Trustees Of Columbia University In The City Of New York |
Phagocyte enhancement therapy for atherosclerosis
|
US7943134B2
(en)
*
|
2005-08-31 |
2011-05-17 |
Academia Sinica |
Compositions and methods for identifying response targets and treating flavivirus infection responses
|
TWI333959B
(en)
*
|
2005-08-31 |
2010-12-01 |
Academia Sinica |
Methods and reagents for the analysis and purification of polysaccharides
|
EP3031470A3
(de)
|
2005-09-09 |
2016-08-10 |
The Johns Hopkins University |
Manipulation der regulatorischen t-zell- und dc-funktion durch targeting des neuritin-gens mit antikörpern, agonisten und antagonisten
|
CA2623415A1
(en)
|
2005-09-20 |
2007-03-29 |
Thrasos, Inc. |
Tdf-related compounds and analogs thereof
|
US8795674B2
(en)
|
2005-09-30 |
2014-08-05 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Methods and compositions for modulating immune tolerance
|
US20070100323A1
(en)
*
|
2005-10-31 |
2007-05-03 |
Ludwig Florian N |
Facilitation of endothelialization by in situ surface modification
|
EP1951737A4
(de)
*
|
2005-11-01 |
2009-07-01 |
Alnylam Pharmaceuticals Inc |
Rnai-hemmung von influenza-virus-neubildungen
|
WO2007056326A2
(en)
*
|
2005-11-04 |
2007-05-18 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of nav1.8 gene
|
WO2007056388A2
(en)
*
|
2005-11-07 |
2007-05-18 |
The General Hospital Corporation |
Compositions and methods for modulating poly (adp-ribose) polymerase activity
|
CA2626690A1
(en)
|
2005-11-09 |
2007-05-18 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of factor v leiden mutant gene
|
DE602005023550D1
(de)
|
2005-12-14 |
2010-10-21 |
Licentia Ltd |
Verwendungen eines neurotrophischen Faktors
|
US8172792B2
(en)
|
2005-12-27 |
2012-05-08 |
Tyco Healthcare Group Lp |
Embolic protection systems for bifurcated conduits
|
DK2264060T3
(da)
|
2006-01-26 |
2014-07-28 |
Recopharma Ab |
Sammensætninger og fremgangsmåder til inhibering af viral adhæsion
|
US8229398B2
(en)
*
|
2006-01-30 |
2012-07-24 |
Qualcomm Incorporated |
GSM authentication in a CDMA network
|
EP1818395A1
(de)
|
2006-02-08 |
2007-08-15 |
Diatos |
Zusammensetzungen und Verfahren zur Behandlung der Lysosomen-Speichererkrankungen
|
EP1994043A4
(de)
|
2006-02-10 |
2009-05-20 |
Univ Cincinnati |
Phosphatasehemmer-protein 1 als regulator der herzfunktion
|
US8222423B2
(en)
*
|
2006-02-14 |
2012-07-17 |
Dana-Farber Cancer Institute, Inc. |
Bifunctional histone deacetylase inhibitors
|
US20090221072A1
(en)
*
|
2006-02-15 |
2009-09-03 |
Chen Thomas T |
Compositions and methods for modulating cell differentiation
|
US20070225750A1
(en)
*
|
2006-03-10 |
2007-09-27 |
Brooke Ren |
Embolic protection systems
|
NZ571568A
(en)
|
2006-03-31 |
2010-11-26 |
Alnylam Pharmaceuticals Inc |
Double-stranded RNA molecule compositions and methods for inhibiting expression of Eg5 gene
|
CA2648322C
(en)
|
2006-04-10 |
2017-11-28 |
Genentech, Inc. |
Disheveled pdz modulators
|
WO2007127919A2
(en)
*
|
2006-04-28 |
2007-11-08 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of a gene from the jc virus
|
WO2007130636A2
(en)
|
2006-05-03 |
2007-11-15 |
Geisinger Clinic |
Methods for diagnosing and predicting non-alcoholic steatohepatitis (nash)
|
CA2654540C
(en)
*
|
2006-05-03 |
2017-01-17 |
President And Fellows Of Harvard College |
Histone deacetylase and tubulin deacetylase inhibitors
|
CN103614375A
(zh)
|
2006-05-11 |
2014-03-05 |
阿尔尼拉姆医药品有限公司 |
抑制pcsk9基因表达的组合物和方法
|
CA2652770A1
(en)
|
2006-05-19 |
2007-11-29 |
Alnylam Pharmaceuticals, Inc. |
Rnai modulation of aha and therapeutic uses thereof
|
WO2007137220A2
(en)
|
2006-05-22 |
2007-11-29 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of ikk-b gene
|
US8383597B2
(en)
*
|
2006-05-25 |
2013-02-26 |
Cornell Research Foundation, Inc. |
G proteins in tumor growth and angiogenesis
|
US8598333B2
(en)
*
|
2006-05-26 |
2013-12-03 |
Alnylam Pharmaceuticals, Inc. |
SiRNA silencing of genes expressed in cancer
|
US8153369B2
(en)
|
2006-06-05 |
2012-04-10 |
Cancer Care Ontario |
Assessment of risk for colorectal cancer
|
US7771401B2
(en)
|
2006-06-08 |
2010-08-10 |
Angiodynamics, Inc. |
Selective renal cannulation and infusion systems and methods
|
EP2044111B1
(de)
*
|
2006-06-21 |
2014-08-13 |
MUSC Foundation For Research Development |
Targeting des komplement-faktors h zur krankheitsbehandlung
|
EP2471815B1
(de)
|
2006-07-11 |
2016-03-30 |
University Of Medicine And Dentistry Of New Jersey |
Proteine, Nukleinsäuren zu deren Kodierung und entsprechende Verwendungsverfahren
|
US20080021063A1
(en)
*
|
2006-07-18 |
2008-01-24 |
Kazantsev Aleksey G |
Compositions and methods for modulating sirtuin activity
|
US8153803B2
(en)
*
|
2006-07-18 |
2012-04-10 |
The General Hospital Corporation |
Compositions and methods for modulating sirtuin activity
|
WO2008028044A2
(en)
*
|
2006-08-30 |
2008-03-06 |
Centocor, Inc. |
Markers and methods for assessing and treating ulcerative colitis and related disorders using 66 gene panel
|
WO2008032210A2
(en)
|
2006-09-14 |
2008-03-20 |
Institut Pasteur |
Methods of using sip-10 to assess hcv clearance and/or response to interferon therapy
|
KR101161923B1
(ko)
|
2006-10-03 |
2012-07-03 |
유니버시티 오브 메디신 앤드 덴티스트리 오브 뉴 저지 |
Atap 펩티드, 상기 펩티드를 엔코딩하는 핵산 및 이들과 관련된 사용 방법
|
US8192363B2
(en)
|
2006-10-27 |
2012-06-05 |
Ekos Corporation |
Catheter with multiple ultrasound radiating members
|
DE102006051623A1
(de)
|
2006-11-02 |
2008-07-31 |
Horn, Peter A. |
Verfahren und Stoffgemisch zur Verbesserung eines in vivo Genfransfers
|
HUE048781T2
(hu)
|
2006-12-21 |
2020-08-28 |
H Lundbeck As |
Proneurotrofinok aktivitásának modulációja
|
US10182833B2
(en)
|
2007-01-08 |
2019-01-22 |
Ekos Corporation |
Power parameters for ultrasonic catheter
|
US7884184B2
(en)
|
2007-01-30 |
2011-02-08 |
Epivax, Inc. |
Regulatory T cell epitopes, compositions and uses thereof
|
WO2008103336A1
(en)
*
|
2007-02-21 |
2008-08-28 |
Cook Incorporated |
Methods for intravascular engraftment in heart
|
US20110189663A1
(en)
|
2007-03-05 |
2011-08-04 |
Cancer Care Ontario |
Assessment of risk for colorectal cancer
|
WO2008116032A1
(en)
|
2007-03-21 |
2008-09-25 |
Effat Emamian |
Compositions and methods for inhibiting tumor cell growth
|
PE20090064A1
(es)
|
2007-03-26 |
2009-03-02 |
Novartis Ag |
Acido ribonucleico de doble cadena para inhibir la expresion del gen e6ap humano y composicion farmaceutica que lo comprende
|
WO2008143774A2
(en)
*
|
2007-05-01 |
2008-11-27 |
University Of Massachusetts |
Methods and compositions for locating snp heterozygosity for allele specific diagnosis and therapy
|
AR066984A1
(es)
*
|
2007-06-15 |
2009-09-23 |
Novartis Ag |
Inhibicion de la expresion de la subunidad alfa del canal epitelial de sodio (enac) por medio de arni (arn de interferencia)
|
US9044568B2
(en)
|
2007-06-22 |
2015-06-02 |
Ekos Corporation |
Method and apparatus for treatment of intracranial hemorrhages
|
US20100184823A1
(en)
|
2007-07-05 |
2010-07-22 |
Mark Aron Labow |
dsRNA For Treating Viral Infection
|
US20090198172A1
(en)
*
|
2008-02-05 |
2009-08-06 |
Garrison Michi E |
Interventional sheath with retention features
|
WO2009012473A2
(en)
|
2007-07-18 |
2009-01-22 |
Silk Road Medical, Inc. |
Methods and systems for establishing retrograde carotid arterial blood flow
|
US8545432B2
(en)
*
|
2009-06-03 |
2013-10-01 |
Silk Road Medical, Inc. |
System and methods for controlling retrograde carotid arterial blood flow
|
US8858490B2
(en)
|
2007-07-18 |
2014-10-14 |
Silk Road Medical, Inc. |
Systems and methods for treating a carotid artery
|
AU2008333811B2
(en)
|
2007-12-04 |
2014-05-01 |
Alnylam Pharmaceuticals, Inc. |
Carbohydrate conjugates as delivery agents for oligonucleotides
|
EP2245159A2
(de)
|
2007-12-10 |
2010-11-03 |
Alnylam Pharmaceuticals Inc. |
Zusammensetzungen und verfahren zur hemmung der expression des faktor-vii-gens
|
US20090176729A1
(en)
*
|
2007-12-14 |
2009-07-09 |
Alnylam Pharmaceuticals, Inc. |
Method of treating neurodegenerative disease
|
EP2245055A2
(de)
*
|
2008-01-31 |
2010-11-03 |
Compugen Ltd. |
Polypeptide und polynukleotide und deren verwendung als arzneimittel-target zur herstellung von arzneimitteln und biologika
|
JP2011510796A
(ja)
|
2008-02-05 |
2011-04-07 |
シルク・ロード・メディカル・インコーポレイテッド |
介入カテーテルシステム及び方法
|
CN101977632A
(zh)
*
|
2008-02-19 |
2011-02-16 |
塞拉东公司 |
用于增强病毒载体于心肌中的摄取的组合物
|
CA2716793A1
(en)
|
2008-03-05 |
2009-09-11 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of eg5 and vegf genes
|
EP2274425A2
(de)
|
2008-04-11 |
2011-01-19 |
Alnylam Pharmaceuticals Inc. |
Stellenspezifische zuführung von nukleinsäuren durch kombinieren zielgerichteter liganden mit endosomolytischen komponenten
|
WO2009134917A2
(en)
*
|
2008-04-29 |
2009-11-05 |
Wyeth |
Methods for treating inflammation
|
FI20080326A0
(fi)
|
2008-04-30 |
2008-04-30 |
Licentia Oy |
Neurotroofinen tekijä MANF ja sen käytöt
|
US20090280134A1
(en)
*
|
2008-05-09 |
2009-11-12 |
Recopharma Ab |
Compositions and methods for inhibiting toxin a from clostridium difficile
|
EP2288624A2
(de)
*
|
2008-05-09 |
2011-03-02 |
Recopharma Ab |
Zusammensetzungen und verfahren zur hemmung von shigatoxin und shiga-like-toxin
|
CA2726804C
(en)
|
2008-06-02 |
2021-12-28 |
Dana-Farber Cancer Institute, Inc. |
Xbp1, cd138, and cs1 peptides
|
JP2011527893A
(ja)
*
|
2008-07-15 |
2011-11-10 |
エフ.ホフマン−ラ ロシュ アーゲー |
TGF−β受容体遺伝子の発現を阻害するための組成物および方法
|
CA2731730C
(en)
*
|
2008-07-23 |
2017-06-13 |
President And Fellows Of Harvard College |
Deacetylase inhibitors and uses thereof
|
US8574245B2
(en)
|
2008-08-13 |
2013-11-05 |
Silk Road Medical, Inc. |
Suture delivery device
|
JP5586607B2
(ja)
*
|
2008-08-29 |
2014-09-10 |
ヤンセン バイオテツク,インコーポレーテツド |
20個の遺伝子パネルを用いて潰瘍性大腸炎及び関連疾患を評価し治療するためのマーカー及び方法
|
EP3208337A1
(de)
|
2008-09-02 |
2017-08-23 |
Alnylam Pharmaceuticals, Inc. |
Zusammensetzungen zur kombinationshemmung der expression eines mutanten egfr und il-6
|
JP5529142B2
(ja)
|
2008-09-25 |
2014-06-25 |
アルナイラム ファーマシューティカルズ, インコーポレイテッド |
血清アミロイドa遺伝子の発現を阻害するための脂質製剤組成物および方法
|
US9207242B2
(en)
|
2008-10-09 |
2015-12-08 |
The University Of Hong Kong |
Cadherin-17 as diagnostic marker and therapeutic target for liver cancer
|
SI2340038T1
(en)
|
2008-10-10 |
2018-05-31 |
Children's Medical Center Corporation |
A biochemically stabilized HIV-1 ENV TRIMER vaccine
|
US8168775B2
(en)
|
2008-10-20 |
2012-05-01 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of transthyretin
|
EP2352998A4
(de)
|
2008-11-07 |
2011-09-21 |
Centocor Ortho Biotech Inc |
Marker und verfahren zur untersuchung und behandlung von lichtreizempfindlichen lupus-patienten
|
AU2009324534B2
(en)
|
2008-12-10 |
2015-07-30 |
Alnylam Pharmaceuticals, Inc. |
GNAQ targeted dsRNA compositions and methods for inhibiting expression
|
US9181315B2
(en)
|
2009-01-08 |
2015-11-10 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for induced brown fat differentiation
|
CA2750459A1
(en)
|
2009-02-03 |
2010-08-12 |
F. Hoffmann-La Roche Ag |
Compositions and methods for inhibiting expression of ptp1b genes
|
WO2010099341A1
(en)
|
2009-02-26 |
2010-09-02 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of mig-12 gene
|
US20100267806A1
(en)
|
2009-03-12 |
2010-10-21 |
David Bumcrot |
LIPID FORMULATED COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF Eg5 AND VEGF GENES
|
EP2411039A4
(de)
|
2009-03-23 |
2015-05-06 |
Brigham & Womens Hospital |
Glycokonjugat-impfstoffe
|
US9675673B2
(en)
*
|
2009-04-24 |
2017-06-13 |
Ingeneron Incorporated |
Transluminal delivery of oncoltyic viruses for cancer therapy
|
EP3421603B1
(de)
|
2009-05-02 |
2021-10-06 |
Genzyme Corporation |
Gentherapie für neurodegenerative erkrankungen
|
SG176099A1
(en)
*
|
2009-05-15 |
2011-12-29 |
Hoffmann La Roche |
Compositions and methods for inhibiting expression of glucocorticoid receptor (gcr) genes
|
CA3120504A1
(en)
|
2009-06-10 |
2010-12-16 |
New York University |
Immunological targeting of pathological tau proteins
|
US9050276B2
(en)
|
2009-06-16 |
2015-06-09 |
The Trustees Of Columbia University In The City Of New York |
Autism-associated biomarkers and uses thereof
|
WO2011005496A2
(en)
|
2009-06-22 |
2011-01-13 |
Massachusetts Eye & Ear Infirmary |
Islet1 (isl1) and hearing loss
|
JP5871798B2
(ja)
|
2009-07-02 |
2016-03-01 |
エムユーエスシー ファウンデーション フォー リサーチ ディベロップメント |
肝再生を刺激する方法
|
WO2011019393A2
(en)
|
2009-08-11 |
2011-02-17 |
President And Fellows Of Harvard College |
Class- and isoform-specific hdac inhibitors and uses thereof
|
US10155099B2
(en)
|
2009-09-21 |
2018-12-18 |
Cook Regentec Llc |
Method for infusing stem cells
|
KR20120130748A
(ko)
|
2009-11-05 |
2012-12-03 |
알렉시온 캠브리지 코포레이션 |
발작성 야간 혈색소뇨증, 용혈성 빈혈, 및 혈관내 및 혈관외 용혈을 수반한 질환 상태의 치료
|
US20110112176A1
(en)
|
2009-11-09 |
2011-05-12 |
John Frederick Boylan |
Compositions and methods for inhibiting expression of kif10 genes
|
EP2499159B1
(de)
|
2009-11-13 |
2017-01-04 |
Dana-Farber Cancer Institute, Inc. |
Zusammensetzungen, kits und verfahren zur diagnose, prognose, überwachung, behandlung und modulierung von auf transplantationen folgenden lymphoproliferativen erkrankungen und hypoxievermittelten angiogeneseerkrankungen mithilfe von galectin-1
|
US20110152349A1
(en)
|
2009-12-18 |
2011-06-23 |
Anke Geick |
Compositions and methods for inhibiting expression of il-18 genes
|
US10429384B2
(en)
|
2010-01-22 |
2019-10-01 |
Dana-Farber Cancer Institute, Inc. |
Compositions, kits, and methods for identification, assessment, prevention, and therapy of metabolic disorders
|
US20110196016A1
(en)
|
2010-02-05 |
2011-08-11 |
Anke Geick |
Compositions and Methods for Inhibiting Expression of IKK2 Genes
|
US9631018B2
(en)
|
2010-03-26 |
2017-04-25 |
The Trustees Of Dartmouth College |
Vista regulatory T cell mediator protein, vista binding agents and use thereof
|
US10745467B2
(en)
|
2010-03-26 |
2020-08-18 |
The Trustees Of Dartmouth College |
VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders
|
US20150231215A1
(en)
|
2012-06-22 |
2015-08-20 |
Randolph J. Noelle |
VISTA Antagonist and Methods of Use
|
ES2893199T3
(es)
|
2010-03-29 |
2022-02-08 |
Alnylam Pharmaceuticals Inc |
Terapia de ARNbc para amiloidosis ocular relacionada con transtiretina (TTR)
|
EP2377888A1
(de)
|
2010-04-07 |
2011-10-19 |
Corimmun GmbH |
Fusionsprotein
|
US11020444B2
(en)
*
|
2010-04-23 |
2021-06-01 |
Scicotec Gmbh |
Transluminal delivery of viruses for treatment of diseased tissue
|
MX2012012567A
(es)
|
2010-04-28 |
2012-11-21 |
Kimberly Clark Co |
Metodo para aumentar la permeabilidad de una barrera epitelial.
|
ES2636673T3
(es)
|
2010-04-28 |
2017-10-06 |
Kimberly-Clark Worldwide, Inc. |
Dispositivo para la administración de medicamentos contra la artritis reumatoide
|
MX2012012317A
(es)
|
2010-04-28 |
2012-11-21 |
Kimberly Clark Co |
Arreglo de microagujas moldeado por inyeccion y metodo para formar el arreglo de microagujas.
|
WO2011135531A2
(en)
*
|
2010-04-28 |
2011-11-03 |
Kimberly-Clark Worldwide, Inc. |
MEDICAL DEVICES FOR DELIVERY OF siRNA
|
US9650447B2
(en)
|
2010-05-14 |
2017-05-16 |
The Regents Of The University Of Colorado, A Body Corporate |
Complement receptor 2 (CR2) targeting groups
|
MX2012014975A
(es)
|
2010-06-22 |
2013-03-12 |
Univ Colorado Regents |
Anticuerpos al fragmento c3d de componente 3 de complemento.
|
CA2809153C
(en)
|
2010-08-27 |
2023-09-26 |
Pantarhei Bioscience B.V. |
Use of hzp3 glycoprotein for treating prostate cancer
|
US9290760B2
(en)
|
2010-09-15 |
2016-03-22 |
Alnylam Pharmaceuticals, Inc. |
Modified iRNA agents
|
US20120076736A1
(en)
*
|
2010-09-17 |
2012-03-29 |
Rochester Institute Of Technology |
Host supported genetic biosensors
|
CN103391784A
(zh)
|
2010-10-15 |
2013-11-13 |
纽约市哥伦比亚大学理事会 |
肥胖症-相关的基因和它们的蛋白和其用途
|
EP3434772A3
(de)
|
2010-10-18 |
2019-03-20 |
Arrowhead Pharmaceuticals, Inc. |
Zusammensetzungen und verfahren zur hemmung der expression von rrm2-genen
|
HUE045869T2
(hu)
|
2010-11-02 |
2020-01-28 |
Univ Columbia |
Módszerek hajhullásos rendellenességek kezelésére
|
WO2012064743A2
(en)
|
2010-11-08 |
2012-05-18 |
The Johns Hopkins University |
Methods for improving heart function
|
GB2485385A
(en)
|
2010-11-12 |
2012-05-16 |
Univ Manchester |
Trimeric fusion protein comprising collagen and a prokaryotic/ viral trimerisation domain
|
US9072766B2
(en)
|
2010-11-18 |
2015-07-07 |
Beth Israel Deaconess Medical Center, Inc. |
Methods of treating obesity by inhibiting nicotinamide N-methyl transferase (NNMT)
|
US9198975B2
(en)
|
2010-12-01 |
2015-12-01 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for targeting sites of neovascular growth
|
AU2011352228B2
(en)
|
2010-12-27 |
2015-12-03 |
Brown University |
Therapeutic and diagnostic methods involving biglycan and utrophin
|
US11458290B2
(en)
|
2011-05-11 |
2022-10-04 |
Ekos Corporation |
Ultrasound system
|
US9592398B2
(en)
|
2011-05-12 |
2017-03-14 |
Medtronic, Inc. |
Leadless implantable medical device with osmotic pump
|
US9068184B2
(en)
|
2011-06-21 |
2015-06-30 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibition of expression of protein C (PROC) genes
|
KR102540778B1
(ko)
|
2011-06-21 |
2023-06-07 |
알닐람 파마슈티칼스 인코포레이티드 |
아포리포단백질 c-iii(apoc3) 유전자의 발현 억제를 위한 조성물 및 방법
|
SG194751A1
(en)
|
2011-06-30 |
2013-12-30 |
Arrowhead Res Corp |
Compositions and methods for inhibiting gene expression of hepatitis b virus
|
WO2013039996A1
(en)
|
2011-09-13 |
2013-03-21 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for brown fat induction and activity using fndc5
|
JP6134725B2
(ja)
|
2011-10-14 |
2017-05-24 |
ジェネンテック, インコーポレイテッド |
Bace1のペプチド阻害剤
|
WO2013055911A1
(en)
|
2011-10-14 |
2013-04-18 |
Dana-Farber Cancer Institute, Inc. |
Znf365/zfp365 biomarker predictive of anti-cancer response
|
WO2013074974A2
(en)
|
2011-11-18 |
2013-05-23 |
Alnylam Pharmaceuticals, Inc. |
Modified rnai agents
|
US9821114B2
(en)
*
|
2012-02-07 |
2017-11-21 |
Global Bio Therapeutics, Inc. |
Compartmentalized method of nucleic acid delivery and compositions and uses thereof
|
PT2814844T
(pt)
|
2012-02-15 |
2017-09-18 |
Novo Nordisk As |
Anticorpos que se ligam e bloqueiam recetor de acionamento expresso em células mieloides-1 (trem-1)
|
SI2814842T1
(sl)
|
2012-02-15 |
2018-10-30 |
Novo Nordisk A/S |
Protitelesa, ki vežejo peptidoglikal prepoznan protein 1
|
US9550830B2
(en)
|
2012-02-15 |
2017-01-24 |
Novo Nordisk A/S |
Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)
|
US10039777B2
(en)
|
2012-03-20 |
2018-08-07 |
Neuro-Lm Sas |
Methods and pharmaceutical compositions of the treatment of autistic syndrome disorders
|
PL2830662T3
(pl)
|
2012-03-29 |
2019-02-28 |
The Trustees Of Columbia University In The City Of New York |
Sposoby leczenia zaburzeń utraty włosów
|
US20150190532A1
(en)
|
2012-04-04 |
2015-07-09 |
The Trustees Of Columbia University In The City Of New York |
Smooth muscle specific inhibition for anti-restenotic therapy
|
CA2875516C
(en)
|
2012-06-05 |
2020-11-03 |
Muffin Incorporated |
Catheter systems and methods useful for cell therapy
|
WO2014039983A1
(en)
|
2012-09-07 |
2014-03-13 |
The Trustees Of Dartmouth College |
Vista modulators for diagnosis and treatment of cancer
|
US9890215B2
(en)
|
2012-06-22 |
2018-02-13 |
King's College London |
Vista modulators for diagnosis and treatment of cancer
|
WO2014018851A1
(en)
|
2012-07-26 |
2014-01-30 |
Joslin Diabetes Center, Inc. |
Predicting and treating diabetic complications
|
WO2014022739A2
(en)
|
2012-08-03 |
2014-02-06 |
Alnylam Pharmaceuticals, Inc. |
Modified rnai agents
|
WO2014022759A1
(en)
|
2012-08-03 |
2014-02-06 |
Dana-Farber Cancer Institute, Inc. |
Agents that modulate immune cell activation and methods of use thereof
|
WO2014028865A1
(en)
|
2012-08-17 |
2014-02-20 |
The Regents Of The University Of Colorado, A Body Corporate |
Compositions and methods for detecting complement activation
|
US10413620B2
(en)
|
2012-08-17 |
2019-09-17 |
The Regents Of The University Of Colorado, A Body Corporate |
Light-emitting versions of the monoclonal antibody to C3D (MAB 3D29) for imaging
|
CN105377288B
(zh)
|
2012-11-05 |
2019-11-15 |
达纳-法伯癌症研究所股份有限公司 |
Xbp1、cd138和cs1肽的组合物制备药物的用途
|
US9340787B2
(en)
|
2012-11-15 |
2016-05-17 |
Yale University |
Compositions and methods of using micro RNAs
|
EP2851086A1
(de)
|
2013-09-20 |
2015-03-25 |
Sanofi |
Serpine: Verfahren zur therapeutischen ß-Zellen-Regeneration und Funktion
|
EP2769732A1
(de)
|
2013-02-22 |
2014-08-27 |
Sanofi |
Serpine: Verfahren zur therapeutischen Beta-Zellen-Regeneration und Funktion
|
US20160002316A1
(en)
|
2013-02-22 |
2016-01-07 |
Joslin Diabetes Center |
Serpins: methods of therapeutic beta-cell regeneration and function
|
SI2968461T1
(sl)
|
2013-03-13 |
2023-01-31 |
Genzyme Corporation |
Fuzijski proteini, ki vsebujejo vezavna dela PDGF in VEGF in postopek njihove uporabe
|
CA2907152A1
(en)
|
2013-03-15 |
2014-09-25 |
The Trustees Of Columbia University In The City Of New York |
Fusion proteins and methods thereof
|
US9822418B2
(en)
|
2013-04-22 |
2017-11-21 |
Icahn School Of Medicine At Mount Sinai |
Mutations in PDGFRB and NOTCH3 as causes of autosomal dominant infantile myofibromatosis
|
AU2013388083B2
(en)
|
2013-05-01 |
2019-08-22 |
Genzyme Corporation |
Compositions and methods for treating spinal muscular atrophy
|
WO2014191630A2
(en)
|
2013-05-28 |
2014-12-04 |
Helsingin Yliopisto |
Non-human animal model encoding a non-functional manf gene
|
US20160122829A1
(en)
|
2013-06-06 |
2016-05-05 |
Dana-Farber Cancer Institute, Inc. |
Compositions and Methods for Identification, Assessment, Prevention, and Treatment of Cancer Using PD-L1 Isoforms
|
MX2015017235A
(es)
|
2013-06-13 |
2017-05-04 |
Orgenesis Ltd |
Poblaciones celulares, metodos de transdiferenciacion y metodos de uso de los mismos.
|
US20160175401A1
(en)
|
2013-07-31 |
2016-06-23 |
Dana-Farber Cancer Institute Inc. |
Compoitions and methods for modulating thermogenesis using pth-related and egf-related compounds
|
CN105813579B
(zh)
|
2013-08-08 |
2019-05-07 |
全球生物疗法有限公司 |
用于微创手术过程的夹具装置和其应用
|
EP3030171B1
(de)
|
2013-08-08 |
2017-11-01 |
Global Bio Therapeutics, Inc. |
Injektionsvorrichtung für minimal invasive eingriffe
|
EP3049442A4
(de)
|
2013-09-26 |
2017-06-28 |
Costim Pharmaceuticals Inc. |
Verfahren zur behandlung von blutkrebs
|
WO2015066190A1
(en)
|
2013-10-29 |
2015-05-07 |
President And Fellows Of Harvard College |
Methods and compositions for inhibting oxidative stress
|
EP3074037B1
(de)
|
2013-11-27 |
2020-10-07 |
Inis Biotech LLC |
Verfahren zur modulierung der angiogenese von auf eine anti-vegf behandlung refraktären karzinomen
|
US11708411B2
(en)
|
2013-12-20 |
2023-07-25 |
Wake Forest University Health Sciences |
Methods and compositions for increasing protective antibody levels induced by pneumococcal polysaccharide vaccines
|
US9682123B2
(en)
|
2013-12-20 |
2017-06-20 |
The Trustees Of Columbia University In The City Of New York |
Methods of treating metabolic disease
|
PL3712174T3
(pl)
|
2013-12-24 |
2022-07-04 |
Janssen Pharmaceutica Nv |
Przeciwciała i fragmenty anty-vista
|
US11014987B2
(en)
|
2013-12-24 |
2021-05-25 |
Janssen Pharmaceutics Nv |
Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
|
WO2015106128A2
(en)
|
2014-01-09 |
2015-07-16 |
Alnylam Pharmaceuticals, Inc. |
MODIFIED RNAi AGENTS
|
US11624093B2
(en)
|
2014-04-24 |
2023-04-11 |
Dana-Farber Cancer Institute, Inc. |
Tumor suppressor and oncogene biomarkers predictive of anti-immune checkpoint inhibitor response
|
MX2016016310A
(es)
|
2014-06-11 |
2017-10-20 |
A Green Kathy |
Uso de agonistas y antagonistas vista para suprimir o aumentar la inmunidad humoral.
|
WO2015191892A2
(en)
|
2014-06-11 |
2015-12-17 |
Beth Israel Deaconess Medical Center, Inc. |
α1-ANTITRYPSIN COMPOSITIONS AND METHODS OF TREATING AUTOIMMUNE DISEASES
|
WO2016011203A1
(en)
|
2014-07-15 |
2016-01-21 |
Life Technologies Corporation |
Compositions with lipid aggregates and methods for efficient delivery of molecules to cells
|
MY178347A
(en)
|
2014-07-17 |
2020-10-08 |
Novo Nordisk As |
Site directed mutagenesis of trem-1 antibodies for decreasing viscosity
|
CN107075516A
(zh)
|
2014-08-20 |
2017-08-18 |
阿尔尼拉姆医药品有限公司 |
经修饰的双链rna试剂
|
WO2016040488A2
(en)
|
2014-09-10 |
2016-03-17 |
Georgetown University |
Compositions and methods of using interleukin-4 induced gene 1 (il4i1)
|
DK3110447T3
(da)
|
2014-09-16 |
2020-06-22 |
Synermore Biologics Co Ltd |
Anti-EGFR-antistof og anvendelser heraf
|
US10092742B2
(en)
|
2014-09-22 |
2018-10-09 |
Ekos Corporation |
Catheter system
|
AU2015328411C1
(en)
|
2014-10-06 |
2022-03-03 |
Dana-Farber Cancer Institute, Inc. |
Angiopoietin-2 biomarkers predictive of anti-immune checkpoint response
|
US10806773B2
(en)
|
2014-10-09 |
2020-10-20 |
Dana-Farber Cancer Institute, Inc. |
Multiple-variable IL-2 dose regimen for treating immune disorders
|
WO2016057693A1
(en)
|
2014-10-10 |
2016-04-14 |
Alnylam Pharmaceuticals, Inc. |
Methods and compositions for inhalation delivery of conjugated oligonucleotide
|
JP7305300B2
(ja)
|
2014-11-05 |
2023-07-10 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
併用免疫療法
|
WO2016080830A2
(en)
|
2014-11-18 |
2016-05-26 |
Pantarhei Bioscience B.V. |
Immunotherapeutic method for treating pancreatic cancer
|
EP3226900A4
(de)
|
2014-12-05 |
2018-09-19 |
Immunext, Inc. |
Identifizierung von vsig8 als vermeintlicher vista-rezeptor und dessen verwendung zur herstellung von vista/vsig8-modulatoren
|
CA2968352A1
(en)
|
2014-12-08 |
2016-06-16 |
Dana-Farber Cancer Institute, Inc. |
Methods for upregulating immune responses using combinations of anti-rgmb and anti-pd-1 agents
|
EP3778644A3
(de)
|
2014-12-23 |
2021-06-02 |
The Trustees of Columbia University in the City of New York |
Fgfr-tacc fusionsproteine und verfahren dafür
|
MA41296A
(fr)
|
2014-12-30 |
2017-11-07 |
Orgenesis Ltd |
Procédés de transdifférenciation et procédés d'utilisation de ceux-ci
|
WO2016131048A1
(en)
|
2015-02-13 |
2016-08-18 |
Icahn School Of Medicine At Mount Sinai |
Rna containing compositions and methods of their use
|
WO2016138287A1
(en)
|
2015-02-25 |
2016-09-01 |
Washington University |
METHODS TO DETECT MOTOR NEURON DISEASE COMPRISING MICRO-RNAs
|
EP3265825A4
(de)
|
2015-03-06 |
2018-08-08 |
Dana-Farber Cancer Institute, Inc. |
Pd-l2-biomarker zur vorhersage von pd-1-weg-inhibitor-reaktionen bei ösophagogastrischem krebs
|
EP3735982A1
(de)
|
2015-03-10 |
2020-11-11 |
The University of Massachusetts |
Abzielung auf gdf6 und bmp-signalisierung für antimelanomtherapie
|
EP3277815B1
(de)
|
2015-04-03 |
2021-09-22 |
University of Massachusetts |
Oligonukleotidverbindungen zur behandlung von präeklampsie und anderen angiogenen erkrankungen
|
CA2980337A1
(en)
|
2015-04-03 |
2016-10-06 |
University Of Massachusetts |
Oligonucleotide compounds for targeting huntingtin mrna
|
CA2982129A1
(en)
|
2015-04-08 |
2016-10-13 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Viral gene therapy as treatment for cholesterol storage disease or disorder
|
CN107735079A
(zh)
|
2015-05-05 |
2018-02-23 |
耶路撒冷希伯来大学伊森姆研究发展有限公司 |
核酸‑阳离子聚合物组合物及其制备和使用方法
|
WO2016183585A1
(en)
|
2015-05-14 |
2016-11-17 |
Joslin Diabetes Center, Inc. |
Retinol-binding protein 3 (rbp3) as a protective factor in non-diabetic retinal degeneration
|
EP3307388B1
(de)
|
2015-06-10 |
2022-06-22 |
Ekos Corporation |
Ultraschallkatheter
|
JP7026509B2
(ja)
|
2015-06-24 |
2022-02-28 |
ヤンセン ファーマシューティカ エヌブイ |
抗vista抗体およびフラグメント
|
CN108135875B
(zh)
|
2015-07-31 |
2021-12-31 |
约翰霍普金斯大学 |
用于治疗代谢重编程病症的方法和组合物
|
SI3328827T1
(sl)
|
2015-07-31 |
2023-11-30 |
The Johns Hopkins University |
Predzdravila glutamin analogov
|
US10842763B2
(en)
|
2015-07-31 |
2020-11-24 |
The Johns Hopkins University |
Methods for cancer and immunotherapy using prodrugs of glutamine analogs
|
AU2016306275A1
(en)
|
2015-08-07 |
2018-02-08 |
Arrowhead Pharmaceuticals, Inc. |
RNAi therapy for Hepatitis B virus infection
|
CA2995110A1
(en)
|
2015-08-14 |
2017-02-23 |
University Of Massachusetts |
Bioactive conjugates for oligonucleotide delivery
|
EP3347486A4
(de)
|
2015-09-09 |
2019-06-19 |
The Trustees of Columbia University in the City of New York |
Reduktion von er-mam-lokalisierten app-c99 und verfahren zur behandlung der alzheimer-krankheit
|
WO2017066796A2
(en)
|
2015-10-16 |
2017-04-20 |
The Children's Medical Center Corporation |
Modulators of telomere disease
|
WO2017066712A2
(en)
|
2015-10-16 |
2017-04-20 |
The Children's Medical Center Corporation |
Modulators of telomere disease
|
US11207393B2
(en)
|
2015-10-16 |
2021-12-28 |
President And Fellows Of Harvard College |
Regulatory T cell PD-1 modulation for regulating T cell effector immune responses
|
US10188750B1
(en)
|
2015-10-23 |
2019-01-29 |
University Of South Florida |
Self-replicating cell selective gene delivery compositions, methods, and uses thereof
|
WO2017075329A2
(en)
|
2015-10-29 |
2017-05-04 |
Dana-Farber Cancer Institute, Inc. |
Methods for identification, assessment, prevention, and treatment of metabolic disorders using pm20d1 and n-lipidated amino acids
|
CA3005878A1
(en)
|
2015-11-19 |
2017-05-26 |
The Brigham And Women's Hospital, Inc. |
Lymphocyte antigen cd5-like (cd5l)-interleukin 12b (p40) heterodimers in immunity
|
ES2835031T3
(es)
|
2016-01-13 |
2021-06-21 |
Genzyme Corp |
Vectores AAV recombinantes que expresan genes osteoprotectores, que incluyen HAS2 y lubricina, útiles en el tratamiento de la osteoartritis y afecciones articulares relacionadas en mamíferos
|
CA3011894A1
(en)
|
2016-01-31 |
2017-08-03 |
University Of Massachusetts |
Branched oligonucleotides
|
CN116920085A
(zh)
|
2016-02-12 |
2023-10-24 |
詹森药业有限公司 |
抗-vista(b7h5)抗体
|
JP2019512271A
(ja)
|
2016-03-21 |
2019-05-16 |
デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド |
T細胞疲弊状態特異的遺伝子発現調節因子およびその使用
|
RU2021111187A
(ru)
|
2016-04-15 |
2021-04-29 |
Янссен Фармасьютикалз, Инк. |
Антитела против человеческого vista и их применение
|
CA2932910A1
(en)
|
2016-06-14 |
2017-12-14 |
Entos Pharmaceuticals Inc. |
Methods for diagnosing and treating metastatic cancer
|
JOP20170161A1
(ar)
|
2016-08-04 |
2019-01-30 |
Arrowhead Pharmaceuticals Inc |
عوامل RNAi للعدوى بفيروس التهاب الكبد ب
|
CA3033368A1
(en)
|
2016-08-12 |
2018-02-15 |
University Of Massachusetts |
Conjugated oligonucleotides
|
JP7466308B2
(ja)
|
2016-09-20 |
2024-04-12 |
デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド |
Usp10バイオマーカーおよびモジュレーターを用いたamlの同定、評価、予防および処置のための組成物および方法
|
US11154591B2
(en)
|
2016-10-14 |
2021-10-26 |
The Trustees Of Columbia University In The City Of New York |
Methods of treating alcohol abuse disorder
|
WO2018075474A1
(en)
|
2016-10-17 |
2018-04-26 |
Medical University Of South Carolina |
Compositions and methods for treating central nervous system injury
|
WO2018085836A1
(en)
|
2016-11-07 |
2018-05-11 |
Colorado State University Research Foundation |
Anti-hiv peptides
|
US10443055B2
(en)
|
2016-12-22 |
2019-10-15 |
Beth Israel Deaconess Medical Center |
Compounds that target MYC microRNA responsive elements for the treatment of MYC-associated cancer
|
EP3609577A4
(de)
|
2017-04-14 |
2021-03-24 |
University of Massachusetts |
Braune fettselektive adipokine
|
EP3635106A4
(de)
|
2017-05-08 |
2021-01-06 |
Orgenesis Ltd. |
Transdifferenzierte zellpopulationen und verfahren zur verwendung davon
|
WO2018226685A2
(en)
|
2017-06-06 |
2018-12-13 |
Dana-Farber Cancer Institute, Inc. |
Methods for sensitizing cancer cells to t cell-mediated killing by modulating molecular pathways
|
CA3068010A1
(en)
|
2017-06-20 |
2018-12-27 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Codon-optimized human npc1 genes for the treatment of niemann-pick type c1 deficiency and related conditions
|
EP3649240A4
(de)
|
2017-07-06 |
2021-07-07 |
Arrowhead Pharmaceuticals, Inc. |
Rnai-agenten zur hemmung der expression von alpha-enac und verwendungsverfahren
|
EP3675897A1
(de)
|
2017-09-01 |
2020-07-08 |
Dana Farber Cancer Institute, Inc. |
Immunogene peptide spezifisch für bcma und taci-antigene zur behandlung von krebs
|
EP3460057A1
(de)
|
2017-09-22 |
2019-03-27 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Kdac varianten und deren nutzung
|
US11441122B2
(en)
|
2017-10-05 |
2022-09-13 |
Epivax Inc. |
Regulatory T cell epitopes
|
EP3728281A1
(de)
|
2017-12-21 |
2020-10-28 |
Alnylam Pharmaceuticals Inc. |
Chiral angereicherte doppelsträngige rna-wirkstoffe
|
US11155618B2
(en)
|
2018-04-02 |
2021-10-26 |
Bristol-Myers Squibb Company |
Anti-TREM-1 antibodies and uses thereof
|
AU2019276372A1
(en)
|
2018-06-01 |
2020-12-24 |
Evotec International Gmbh |
Combination therapy for treating hepatitis B virus infection
|
KR20210054502A
(ko)
|
2018-06-21 |
2021-05-13 |
유니버시티 오브 로체스터 |
헌팅턴병을 치료하거나 이의 발병을 저해하는 방법
|
JP2021533762A
(ja)
|
2018-08-10 |
2021-12-09 |
ユニバーシティ・オブ・マサチューセッツUniversity Of Massachusetts |
Snpを標的化する修飾オリゴヌクレオチド
|
EP3626820A1
(de)
|
2018-09-20 |
2020-03-25 |
Fundación Imdea Nanociencia |
Krebsbekämpfende zusammensetzungen mit mirna-imitatoren und verwendungen davon
|
US20220056444A1
(en)
|
2018-12-05 |
2022-02-24 |
Empirico Inc. |
Process to inhibit or eliminate eosinophilic diseases of the airway and related conditions
|
US11116778B2
(en)
|
2019-01-15 |
2021-09-14 |
Empirico Inc. |
Prodrugs of ALOX-15 inhibitors and methods of using the same
|
WO2020167822A2
(en)
|
2019-02-13 |
2020-08-20 |
University Of Rochester |
Gene networks that mediate remyelination of the human brain
|
EP3941938A1
(de)
|
2019-03-06 |
2022-01-26 |
Dana-Farber Cancer Institute, Inc. |
Für das b-zell-reifungsantigen spezifische t-zell-rezeptoren zur behandlung von krebs
|
MX2021011928A
(es)
|
2019-03-29 |
2022-01-04 |
Dicerna Pharmaceuticals Inc |
Composiciones y metodos para el tratamiento de enfermedades o trastornos asociados con kras.
|
CN114072501A
(zh)
|
2019-05-06 |
2022-02-18 |
马萨诸塞大学 |
抗c9orf72寡核苷酸及相关方法
|
US11905523B2
(en)
|
2019-10-17 |
2024-02-20 |
Ginkgo Bioworks, Inc. |
Adeno-associated viral vectors for treatment of Niemann-Pick Disease type-C
|
US20230242655A1
(en)
|
2019-12-03 |
2023-08-03 |
Evotec International Gmbh |
Interferon-associated antigen binding proteins and uses thereof
|
JP2023505169A
(ja)
|
2019-12-03 |
2023-02-08 |
エヴォテック・インターナショナル・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング |
B型肝炎感染の治療における使用のためのインターフェロン会合抗原結合タンパク質
|
WO2021141733A1
(en)
|
2020-01-07 |
2021-07-15 |
The Procter & Gamble Company |
Method of modulating a fibrotic condition
|
CA3189732A1
(en)
|
2020-07-20 |
2022-01-27 |
Dana-Farber Cancer Institute, Inc. |
Methods and compositions for treatment and prevention of coronavirus infection
|
WO2022086852A2
(en)
|
2020-10-19 |
2022-04-28 |
Dana-Farber Cancer Institute, Inc. |
Germline biomarkers of clinical response and benefit to immune checkpoint inhibitor therapy
|
WO2022159793A2
(en)
|
2021-01-25 |
2022-07-28 |
Dana-Farber Cancer Institute, Inc. |
Methods and compositions for identifying neuroendocrine prostate cancer
|
AU2022218771A1
(en)
|
2021-02-11 |
2023-08-24 |
Dana-Farber Cancer Institute, Inc. |
Methods of treating cancers using sting agonists
|
KR20230165212A
(ko)
|
2021-03-02 |
2023-12-05 |
다나-파버 캔서 인스티튜트 인크. |
적혈구 장애의 치료 방법
|
WO2022240741A1
(en)
|
2021-05-12 |
2022-11-17 |
Dana-Farber Cancer Institute, Inc. |
Lag3 and gal3 inhibitory agents, xbp1, cs1, and cd138 peptides, and methods of use thereof
|
WO2022261183A2
(en)
|
2021-06-08 |
2022-12-15 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for treating and/or identifying an agent for treating intestinal cancers
|
EP4351732A1
(de)
|
2021-06-09 |
2024-04-17 |
Evotec International GmbH |
Interferon-assoziierte antigenbindende proteine zur verwendung zur behandlung oder prävention von coronavirus-infektionen
|
EP4359539A1
(de)
|
2021-06-23 |
2024-05-01 |
University Of Massachusetts |
Optimierte anti-flt1-oligonukleotidverbindungen zur behandlung von präeklampsie und anderen angiogenen erkrankungen
|
WO2023280988A1
(en)
|
2021-07-09 |
2023-01-12 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for improving relaxation of striated myocytes
|
US20230270818A1
(en)
|
2021-11-02 |
2023-08-31 |
University Of Rochester |
Tcf7l2 mediated remyelination in the brain
|
WO2023097119A2
(en)
|
2021-11-29 |
2023-06-01 |
Dana-Farber Cancer Institute, Inc. |
Methods and compositions to modulate riok2
|
WO2023158732A1
(en)
|
2022-02-16 |
2023-08-24 |
Dana-Farber Cancer Institute, Inc. |
Methods for decreasing pathologic alpha-synuclein using agents that modulate fndc5 or biologically active fragments thereof
|